Delivery Order SPE2DB20D3101-SPE2DB25FRSG6
- Not listed
- The Defense Logistics Agency awarded a $1,051.18 delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Dexcom G7 sensors, continuous glucose monitoring devices used for diabetes management. This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical supply vehicle valued through December 2026. The...
- The Defense Logistics Agency awarded a $35,386.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dexcom G7 continuous glucose monitoring sensors, with performance at the company's Conshohocken, Pennsylvania facility and completion by June 2, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 through...
- The Defense Logistics Agency awarded a $2,280.80 delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors, with an ultimate completion date of August 8, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,546.80 to AmerisourceBergen Drug Corp for the supply of Dexcom G7 sensors. This contract was competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of August 12, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's broader...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $1,023.62 firm fixed-price delivery order for Dexcom G7 sensors, with an ultimate completion date of September 5, 2025. This competitively awarded contract, issued on September 4, 2025, represents a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Dexcom G7 continuous glucose monitoring sensors, valued at $1,180.24. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by September 11, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,493.49 to AmerisourceBergen Drug Corp for Dexcom G7 sensors, with a completion date of July 21, 2025. This firm fixed-price delivery order, issued on July 18, 2025, represents a competitively awarded transaction with no set-aside designation. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a $1,000.05 firm fixed price delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors under contract number 4568433826. This is a non-set-aside competitive award with a completion date of June 3, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,456.25 to AmerisourceBergen Drug Corp for Dexcom G7 continuous glucose monitoring sensors. This contract was competitively awarded with no set-aside designation and carries a firm fixed price structure with a completion date of September 16, 2025. The award represents a continuation of AmerisourceBergen's role as a critical supplier of medical devices and pharmaceutical products to the Department of Defense and related federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,007.81 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on June 25, 2025, with completion scheduled for June 26, 2025. This firm fixed price, non-set-aside delivery order represents a continuation of federal medical supply procurement through the company's existing contract vehicle with DLA. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical and medical device distributor...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRSG6Delivery Order
The Defense Logistics Agency awarded a $5,156.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dexcom G7 continuous glucose monitoring sensors. The order was competitively awarded without a set-aside designation and carries an ultimate completion date of August 12, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The Dexcom G7 sensors are diabetes management medical devices that support military healthcare operations and veteran medical systems through the DLA's medical supply chain. AmerisourceBergen's comprehensive IDC vehicle enables the company to supply a broad range of pharmaceutical products and medical devices across multiple therapeutic domains to support Defense Health Agency and other federal healthcare customers globally. This specific delivery order for continuous glucose monitoring devices aligns with the Defense Logistics Agency's mission to provide critical medical commodities to military personnel and beneficiaries, demonstrating the agency's procurement of modern diabetes care technology for enhanced patient outcomes within the military healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 8/11/25 |